Evaxion biotech a
WebJan 25, 2024 · Evaxion Biotech, a Danish Phase 1/2 biotech using AI to develop immuno-oncology therapies, announced terms for its IPO on Monday. The Copenhagen, Denmark-based company plans to raise $30... WebMar 6, 2024 · Latest Evaxion Biotech A/S - ADR Stock News. As of March 03, 2024, Evaxion Biotech A/S - ADR had a $34.2 million market capitalization, putting it in the 21st percentile of companies in the Biotechnology & Medical Research industry. Evaxion Biotech A/S - ADR does not have a meaningful P/E due to negative earnings over the …
Evaxion biotech a
Did you know?
WebApr 13, 2024 · Evaxion has a broad pipeline of product candidates, including three personalized cancer immunotherapies. The company is located in Hørsholm, Denmark, … WebAnalyst Ratings Evaxion Biotech A/S ADR Stock Price Target EVAX Advertisement Options Overview Research & Ratings Stocks: Real-time U.S. stock quotes reflect trades …
WebApr 13, 2024 · About Evaxion Evaxion Biotech A/S is a clinical-stage biotech company developing AI-powered immunotherapies. Evaxion’s proprietary and scalable AI technologies decode the human immune system to discover and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. WebGet the latest Evaxion Biotech A/S - ADR (EVAX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
WebApr 6, 2024 · Biotechnology Employees 61 Founded 2008 Address Dr. Neergaards Vej 5th Floor Horsholm, 2970 Denmark Phone Number 45 53 53 18 50 Website www.evaxion … WebMar 28, 2024 · Evaxion Biotech A/S is a pioneering company developing AI-powered immunotherapies. Evaxion's proprietary and scalable AI technologies decode the human immune system to discover and develop...
WebNov 1, 2024 · With a market capitalization of US$146m, Evaxion Biotech is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the …
WebMar 22, 2024 · COPENHAGEN, Denmark, March 22, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced today the fourth quarter and full-year 2024 financial results and provided an … magnetite beneficiation processWeb1 day ago · Evaxion has a broad pipeline of product candidates, including three personalized cancer immunotherapies. The company is located in Hørsholm, Denmark, … cppd unifalWebEvaxion-Biotech A/S (NASDAQ:EVAX) is a clinical-stage biotech company developing AI-powered immunotherapies for the treatment of various cancers, bacterial diseases and … magnetite black metallic benz paint colorWebEvaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapy This potentially enables treatment for patients with cold tumors, normally … cppd terminal illnessWebApr 14, 2024 · Evaxion Biotech A/S currently has a consensus target price of $9.00, indicating a potential upside of 643.80%. Opthea has a consensus target price of $23.00, … magnetite formula chimicaWebApr 6, 2024 · Evaxion Biotech stock price target cut to $11 from $16 at Oppenheimer. Nov. 17, 2024 at 7:39 a.m. ET by Tomi Kilgore. cppd unilabWebPer-Share Earnings, Actuals & Estimates Evaxion Biotech A/S ADR Quarterly Annual Actual Analyst Range Consensus 0.20 0.00 -0.20 EVAX will report Q4 earnings on … cppd unifesspa